Главная » Respiratory Diseases

Medical Clinic License


Лицензия

Respiratory Diseases
Diseases of the respiratory system account for about 12% of the total incidence, are therefore actual both medical and social problem.

The most common are:
• acute and chronic laringopharingitis,
• tonsillitis
• adenoid vegetation
• sinusitis,
• bronchitis

• pneumonia
• bronchial asthma,
• acute and chronic otitis.
• In the last decade, a proliferation of dysplastic epithelial changes of bronchial tree.

The cause of most respiratory diseases are:
• Viruses, bacteria, fungi;
• chemical substances and dust, smoking, and exo-and endoallergens;
• adverse weather and environmental factors;
• Genetic predisposition is important
The most frequent complaints of these patients are: dry or wet cough, shortness of breath, limitation of inhalation and exhalation, the frequent attacks of breathlessness.
This leads to disruption of oxygen to the body and its participation in metabolic processes at the cellular and tissue levels.

There occurred the so-called oxygen starvation of tissues (hypoxia) and accumulation of incompletely oxidized products (lipids, proteins), leading to disruption of the structure and function of cells. The patient has decreased resistance to adversity, dramatically weakened immune system, and as a result of circulatory insufficiency, the cardiovascular disease develops.

Bronchial asthma (gr. asthma - heavy breathing) - a chronic disease characterized by sustained inflammation of respiratory tract infections. The disease can occur either as single episodes, or severe, recurrent seizures that result in death.
In the development of bronchial asthma internal and external factors are playing the role

Internal factors of developing asthma: a violation of the sensitivity of the bronchs (may be hereditary), defects in the immune system, disorders of the endocrine system, etc.

External factors of developing asthma are: allergy, mechanical stimuli, chemical irritants, stress, physical overload, infections (fungi, viruses, bacterial). One of the most common forms is considered to be allergy to the dust.

Symptoms of the bronchial asthma:

- Asthma attacks, often at night,

-shortness of breath, difficulty with exhalation

- Wheezing,

- Cough

- Increase in body temperature (in the amplification of activity of bronchopulmonary infection).

 

Tuberculosis, is one of the most common diseases in the world. The tuberculosis stimulus - tuberculosis mycobacterium (MBT).

MBT is:
• human,
• bull,
• bird,
• mouse.

The disease is characterized by the development of cell allergies, specific granulomas in various organs and tissues of the polymorphic clinical picture. Tuberculosis affects the lungs, lymph system, bones, joints, genito-urinary organs, skin, eyes and nervous system. If untreated, tuberculosis progresses.

In 1882, the German Robert Koch proved the infectious nature of TB. It was he who discovered Mycobacterium provoking disease and called it the "tubercle bacillus". Mycobacterium tuberculosis is extremely tenacious, resistant to alcohol, alkalis and acids. They just die under prolonged exposure to chlorine-containing substances and high temperatures.

Modes of transmission of tuberculosis from human to human:
• aerogenic (airborne and dust).
• Alimentary (through foods and patient’s dishes).

Every person with active TB can infect bacillary an average of 10-15 people. Although tuberculosis is not highly contagious diseases attributed to, 25-50% close and prolonged contact with the smear, infected. Catching TB – does not mean to be sick.

Many produced during infection unsterile immunity, and only 5-15% of those infected become ill. Particularly communicable tuberculosis patients are bronchus, larynx, and destructive forms of pulmonary tuberculosis.

Treatment of tuberculosis

Almost all patients with tuberculosis diagnosed for the first time, can be cured. Tuberculosis treatment is carried out with anti-TB drugs in combination with physical therapy, respiratory exercises and drugs raising immunity.

Treatment

Spectrum of expected pharmacological drugs for treatment of chronic diseases of the respiratory system is quite diverse. Unfortunately, the drug treatment is ineffective and unjustified use of antibiotics leads to candida infections, goiter. On this problem for over 16 years an academician, doctor of traditional medicine, Gagik Sarkisovich Avakyan, has been working.

Academician G.S. Avakyan has developed a unique method of a comprehensive phytotherapy for respiratory diseases with the use of biologically active compounds of higher vascular plants (endemic), stabilizing the disturbed metabolism of the lung tissue.

This unique method of treatment of diseases of the respiratory complex pharmacological and herbs is authored and is the result of years of research and practice of Dr. Avakyan.

He investigated the action of many species of rare medicinal herbs and isolated from their biologically active substances that are both powerful antioxidants block the free-radical reactions and are involved in processes of tissue respiration.

These pharmacological properties of biologically active substances of medicinal plants increase resistance to blood vessels, improve blood circulation in brain and peripheral,  preventing the spread of infection and inhibit the inflammatory processes that increase the immune response that prevents bacteria overgrowth. In addition, the body is enriched with vitamins, trace elements, AMK, present in the collections.
Statistics
The clinic of Academician G.S. Avakyan for 1999-2005 y.y. examined the results of treatment of 468 patients, suffering from various acute or chronic respiratory diseases. Men were 282, women - 186. Disease duration ranged from 1 year to 10 years.

The main complaints handling were:

dry or productive cough (81%);
nasal congestion (59%)
syndrome with obstruction of the discharge of viscous mucus (56%);
shortness of breath (78%);
frequent attacks of breathlessness (39%);
allergic predisposition (85.5%)
pain and dryness in the throat (43%)
candidosis of the mucous membranes of the upper respiratory tract infection (29%).

Depending on the severity of the disease, stage, presence of complications, associated diagnoses, depending on the hormonal drugs, allergic predisposition combination and dose of drugs and herbs changed. The course of treatment was 2 years.

Assessment of treatment outcomes was conducted independently by patients with special questionnaires, and when you visit the clinic - in a study of otolaryngologic status, audiograms, bronchoscopy before and after treatment. The evaluation was conducted in the dynamics (6, 12 and 24 months).
The results of treatment were different. So, after 1 month of the beginning, treatment  84% ​​cough was gone, in 81% reduction in the number of attacks of breathlessness in 2-3 times, in 43% shortness of breath disappeared, in 82% -  restored nasal breathing, 69% recovered hearing, in 76% increased external respiration function and increased volume of inhalation and exhalation, and in 29% restored the structure of the epithelial layer.
Contraindications to receive herbs: Individual intolerance of medicinal herbs.